We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Duchenne Community Submits Patient-Initiated Draft Guidance to FDA
Duchenne Community Submits Patient-Initiated Draft Guidance to FDA
July 10, 2014
The Duchenne muscular dystrophy community wants the FDA to consider patients’ and caregivers’ views when conducting risk-benefit analyses in clinical trials of new treatments for the disease.